Suchergebnisse - "van Dam, Koos P.J."

PubPharm (22)

1

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

enthalten in: Journal of autoimmunity | 2024

von van den Dijssel, J. | Duurland, M. | Konijn, V. | +77

2

T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2024

von Verstegen, N. | Hagen, R. | Kreher, C. | +71

3

Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von van Kempen, Z. | van Dam, K. | Keijser, J. | +11

4

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination

enthalten in: Allergy | 2024

von Valk, A. | Keijser, J. | van Dam, K. | +28

5

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

enthalten in: Frontiers in immunology | 2024

von Keijzer, S. | Oskam, N. | Ooijevaar-de Heer, P. | +14

6

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination

enthalten in: bioRxiv.org | 2023

von Valk, A. | Keijser, J. | van Dam, K. | +27

7

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases : long-term humoral immune responses and effects on disease activity

enthalten in: BMC infectious diseases | 2023

von van Dam, K. | Volkers, A. | Wieske, L. | +55

8

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

enthalten in: BMC infectious diseases | 2023

von van Dam, K. | Volkers, A. | Wieske, L. | +54

9

SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2023

von van Kempen, Z. | Stalman, E. | Steenhuis, M. | +58

10

Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

enthalten in: Annals of neurology | 2023

von van Kempen, Z. | Hogenboom, L. | Toorop, A. | +16